Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency

Ítems similars

• Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants
  per: Frey, Kathleen M., et al.
  Publicat: (2015)
• Efficient Discovery of Potent Anti-HIV Agents Targeting the Tyr181Cys Variant of HIV Reverse Transcriptase
  per: Jorgensen, William L., et al.
  Publicat: (2011)
• Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group
  per: Lee, Won-Gil, et al.
  Publicat: (2013)
• Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
  per: Lee, Won-Gil, et al.
  Publicat: (2014)
• Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase
  per: Frey, Kathleen M., et al.
  Publicat: (2014)